HOME SPEAKERS AGENDA REGISTRATION HOTEL
     
 

Conference Introduction

CTIC Capital is committed to create valuable connections for US companies that are interested in raising capital and developing business relationships in China.
Get ready to pitch
We will bring you Chinese investors (100+) who are actively searching for US investment and business collaboration opportunities.
 
Get ready to be inspired
Impressive line up of investors from US and China to share challenges and opportunities in areas such as: Precision Medicine, Early Drug Development, Medical Devices, Cross Border M&A, Fund Raising and more.
 
Get ready to connect
Mobile APP would assist you in submitting inquiries of one-on-one investors meetings before and during the conf--erence.
 

CONFIRMED SPEAKERS

ROBERT S. LANGER
The David H. Koch Institute Professor, Massachusetts Institute of Technology
 
STEVE Q. YANG
SVP and COO,
WuXi AppTec
 
DAVID BERRY
General Partner,
Flagship Ventures
 
FRANK JIANG
MD, PhD, CEO, CStone Pharma
HEMANT TANEJA
Managing Director,
General Catalyst Partners
 
CHEN YU
Managing Partner,
Vivo Capital
 
KEVIN CHEN
Partner, Sequoia China
 
STEVEN WANG
Managing and Founding Partner,
HighLight Capital
VICTOR SHI
Founding President, QIAGEN Asia Pacific; General Partner, Serica Capital
 
JINSHENG REN
Chairman and Chief Executive
Officer, Simcere
 
DONGLIANG GE
President, BioScikin Co., Ltd.
 
YAOMING LIANG
Chairman of the Board and CEO, KingsMed Diagnostics
RICHARD ZHAO
Investment & Sr. Vice President, Medical Device, Fosun Pharma
 
TED DRISCOLL
Partner, Decheng Capital
 
KEWEN JIN
Chairman, BayHelix,
Managing Partner, Serica Capital
 
SKIP FLESHMAN
Partner,
Asset Management Ventures
NEIL EXTER
Partner,
Third Rock Ventures
 
STEVEN WANG
Managing Director,
CITIC PE
 
JENNIFER HU
Venture Partner
Qiming Ventures
 
CHRISTOPHER VON JAKO
President and CEO
NinePoint Medical
YANHONG LIN
Founder and Managing Partner,
CTIC Capital
 
ELAD GIL
CEO,
Color Genomics
 
CLARENCE KHO
Managing Director,
Converge Minds
 
JIMMY ZHANG
Managing Director,
CL Investment Group
VINCENT XIANG
Ph.D, MBA Partner
Frontline BioVentures
 
XIANGYU OUYANG
Managing Director
Legend Capital
 
DAJUN YANG
M.D., Ph.D., Chairman & CEO
Ascentage Pharma Group
 
BIN SUN
Head and Managing Director,
CEL Healthcare Fund
 

PARTICIPATING VENTURE FIRMS AND CORPORATIONS

 
 
 
 
 
 
 
 
 

PARTIAL PARTICIPATING COMPANIES

 
 

PRELIMINARY AGENDA

 
  08:00-10:15 am Investors & Companies One-on-One Meetings / Company Exhibition
Continental Breakfast
  10:15-10:20 am Welcoming Remarks
Yanhong Lin, Managing Partner, CTIC Capital
  10:20-11:10 am Keynote & Award Ceremony - Creating and Implementing Novel Biomedical Technologies
Robert S. Langer, David H. Koch Institute Professor, MIT
  11:10-11:40 am Fireside Chat: Precision medicine
Hemant Taneja, Managing Director, General Catalyst Partners
Elad Gil, CEO, Color Genomics
  11:40-12:20 pm Panel Discussion – 2017 Cross Border Investment Opportunities and Challenges
Kevin Chen, Partner, Sequoia China
Steven Wang, Partner, Highlight Capital
Chen Yu, Vivo Capital
Kewen Jin, Chairman of BayHelix & Managing Partner, Serica Capital
Xiangyu Ouyang, Managing Director, Legend Capital
  12:20-01:20 pm Lunch / One-on-One Meetings
  01:20-01:40 pm Keynote - Innovation and Collaboration Ecosystem and Platform
Steve Yang, SVP and COO, WuXi AppTec
  01:40-02:20 pm Panel Discussion II – US China Partnerships and M&A Opportunities
Victor Shi, Founding President, QIAGEN Asia Pacific; General Partner, Serica Capital
Jennifer Hu, Partner, Qiming Ventures
Richard Zhao, GM Strategy and Investment & Senior Vice President, Medical Device
Steven Wang, Managing Director, CITIC PE
Jimmy Zhang, CLI Ventures
  02:20-03:00 pm Panel Discussion III – Future of US Healthcare Investments (where would the funding go in 2017 and beyond)
Skip Fleshman, Managing Partner, AMV
David Berry, General Partner, Flagship Ventures
Ted Driscoll, Partner, Decheng Capital
Neil Exter, Partner, Third Rock Ventures
  03:00-03:10 pm Break
  03:10-04:00 pm Breakout Panel A - Future of In Vitro Diagnostic Tools
Yaoming Liang, Chairman, KingMed Diagnostics
Dongliang Ge, President, BioScikin Co.
Breakout Panel B - New Drug Development: The Promise and The Pitfalls
Frank Jiang, CEO, CStone Pharmaceuticals
Vincent Xiang, Partner, Frontline BioVentures
Dajun Yang, CEO, Ascentage Pharma Group
Breakout Panel C - Medical Device & MedTech: Is China the New Exit
Christopher von Jako, President and CEO, NinePoint Medical
Clarence Kho, Managing Director, Converge Minds
Bin Sun, Managing Director, CEL Healthcare Fund
  04:00-06:00 pm One-on-One Meetings and Networking
     
 

CONTACT US

 
ning.feng@cticcapital.com
yanhong.lin@cticcapital.com